Latest Capital Raisings News

Australian Dairy Nutritionals reported a 54% year-on-year revenue fall in the September quarter and held just A$513,000 in cash against a A$619,000 operating cash outflow. The infant formula group is pursuing a A$500,000 placement and a broader capital raise as it waits for China distribution growth and Vietnam sales to rebuild momentum.

Overwatch Technologies is seeking A$8 million to fund an ASX listing and expand its drone-enabled maritime intelligence business. The company has A$3.8 million of contracted orders, but has yet to recognise revenue and reported an inaugural loss of A$857,604.

Qualitas delivered record deployment and stronger earnings in FY26, while raising its dividend and entering Europe through the Starz Real Estate acquisition. The alternative investment manager is guiding to normalised NPBT of $74 million to $80 million for FY27, subject to market conditions.

L1 Group’s funds under management rose to $19.3 billion in the September quarter, marking a fourth consecutive quarter of net client inflows. Growth was strongest in Long Short strategies and Gold, although Platinum outflows continued and a new Global Long Short capital raising is still in progress.

Multistack International reported $246,093 in cash at 30 September after burning $115,313 on operations during the quarter. With no financing facilities disclosed and no replacement business yet identified, the company says it is investigating opportunities while continuing to meet its ASX obligations.

Podium Minerals has improved flotation recovery at its Parks Reef PGM project to 67% while maintaining overall concentrator recovery near 80%, with a smaller targeted downstream circuit. The September quarter also delivered the full A$4 million underwritten raising and a proposed Australia-US processing partnership, though both the flowsheet and funding pathway still require further validation.

Latrobe Magnesium has given eligible shareholders an additional 10 days to participate in its fully underwritten entitlement offer, citing market volatility and delays in receiving offer documents. The revised deadline is 26 October, with new shares expected to begin trading on 3 November.

FOS Capital has started FY27 ahead of its own expectations, reporting a 64% rise in quarterly sales and a stronger-than-forecast EBITDA result. The order book has expanded to $10.5 million, while major lighting wins and a $130 million quote pipeline support management’s expectation of similarly strong sales in 2Q27.

Excite Technology Services has reported its strongest quarterly operating cash flow on record, with A$1.33 million generated in the September quarter and cash reserves rising to A$3.98 million. The result was supported by stronger customer receipts, a A$3.20 million Federal Government digital forensics contract and a July capital raising.

Zenith Minerals has reaffirmed its support for Forrestania Resources’ takeover, arguing that the completed Edna May acquisition and A$310 million capital raising outweigh a sharply lower implied offer value. The recommendation comes with a clear split: long-term shareholders may favour the combination, while shorter-term holders may reasonably reject it.

Volt Resources has secured a $1.5 million placement to fund its Alabama high-purity graphite refinery study, advance pilot work and reduce debt. Almost half the raise is subscribed by two directors, although their participation still requires shareholder approval.

Prescient Therapeutics has reached the first planned review threshold in its PTX-100 Phase 2a lymphoma study, while a completed A$6.0 million raise extends funding beyond the December milestone. The review will assess safety and efficacy, but is not a study completion or a new clinical result.